|
1
|
Kawasaki T: Acute febrile mucocutaneous
syndrome with lymphoid involvement with specific desquamation of
the fingers and toes in children. Arerugi. 16:178–222.
1967.PubMed/NCBI(In Japanese).
|
|
2
|
Galeotti C, Kaveri SV, Cimaz R, Koné-Paut
I and Bayry J: Predisposing factors, pathogenesis and therapeutic
intervention of Kawasaki disease. Drug Discov Today. 21:1850–1857.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mccrindle BW, Rowley AH, Newburger JW,
Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M,
Shah P, et al: Diagnosis, treatment, and long-term management of
kawasaki disease: A scientific statement for health professionals
from the American Heart Association. Circulation. 135:e927–e999.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bayers S, Shulman ST and Paller AS:
Kawasaki disease: Part I. Diagnosis, clinical features, and
pathogenesis. J Am Acad Dermatol. 69:501.e1–e11. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Takahashi K, Oharaseki T and Yokouchi Y:
Pathogenesis of Kawasaki disease. Clin Exp Immunol. 164 (Suppl
1):S20–S22. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Takahashi K, Oharaseki T and Yokouchi Y:
Update on etio and immunopathogenesis of Kawasaki disease. Curr
Opin Rheumatol. 26:31–36. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Orenstein JM, Shulman ST, Fox LM, Baker
SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarévian JP,
Perlman EJ, et al: Three linked vasculopathic processes
characterize Kawasaki disease: A light and transmission electron
microscopic study. PLoS One. 7(e38998)2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sallam T, Sandhu J and Tontonoz P: Long
noncoding RNA discovery in cardiovascular disease: Decoding form to
function. Circ Res. 122(155)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Muta H, Ishii M, Yashiro M, Uehara R and
Nakamura Y: Late intravenous immunoglobulin treatment in patients
with Kawasaki disease. Pediatrics. 129:e291–e297. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang KC, Yamada KA, Patel AY, Topkara VK,
George I, Cheema FH, Ewald GA, Mann DL and Nerbonne JM: Deep RNA
sequencing reveals dynamic regulation of myocardial noncoding RNAs
in failing human heart and remodeling with mechanical circulatory
support. Circulation. 129:1009–1021. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cooper C, Vincett D, Yan Y, Hamedani MK,
Myal Y and Leygue E: Steroid receptor RNA activator bi-faceted
genetic system: Heads or Tails? Biochimie. 93:1973–1980.
2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yatagai Y, Hirota T, Sakamoto T, Yamada H,
Masuko H, Kaneko Y, Iijima H, Naito T, Noguchi E, Tamari M, et al:
Variants near the HLA complex group 22 gene (HCG22) confer
increased susceptibility to late-onset asthma in Japanese
populations. J Allergy Clin Immunol. 138:281–283.e13.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Taniguchi N, Konno S, Hattori T, Isada A,
Shimizu K, Shimizu K, Shijubo N, Huang SK, Hizawa N and Nishimura
M: The CC16 A38G polymorphism is associated with asymptomatic
airway hyper-responsiveness and development of late-onset asthma.
Ann Allergy Asthma Immunol. 111:376–381.e1. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Meder B, Rühle F, Weis T, Homuth G, Keller
A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, et al: A
genome-wide association study identifies 6p21 as novel risk locus
for dilated cardiomyopathy. Eur Heart J. 35:1069–1077.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lu F, Houck JR, Lohavanichbutr P and Chen
C: Transcriptome analysis reveals differentially expressed lncRNAs
between oral squamous cell carcinoma and healthy oral mucosa.
Oncotarget. 8:31521–31531. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Amano S, Hazama F, Kubagawa H, Tasaka K,
Haebara H and Hamashima Y: General pathology of Kawasaki disease:
On the morphological alterations corresponding to the clinical
manifestations. Acta Pathol Jpn. 30:681–694. 1980.PubMed/NCBI
|
|
20
|
Cabana VG, Gidding SS, Getz GS, Chapman J
and Shulman ST: Serum amyloid A and high density lipoprotein
participate in the acute phase response of Kawasaki disease.
Pediatr Res. 42:651–655. 1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chiang AN, Hwang B, Shaw GC, Lee BC, Lu
JH, Meng CC and Chou P: Changes in plasma levels of lipids and
lipoprotein composition in patients with Kawasaki disease. Clin
Chim Acta. 260:15–26. 1997.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Galeotti C, Bayry J, Kone-Paut I and
Kaveri SV: Kawasaki disease: Aetiopathogenesis and therapeutic
utility of intravenous immunoglobulin. Autoimmun Rev. 9:441–448.
2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nonoyama S: Immunological abnormalities
and endothelial cell injury in Kawasaki disease. Acta Paediatr Jpn.
33:752–755. 1991.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mostafavi N, Haghjooy-Javanmard S,
Presidend N, Manssori NS and Kelishadi R: Persistence of
endothelial cell damage late after Kawasaki disease in patients
without coronary artery complications. Adv Biomed Res.
4(25)2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Leung DY: Clinical and immunologic aspects
of Kawasaki disease. Immunodefic Rev. 1:261–271. 1989.PubMed/NCBI
|
|
26
|
Han P, Li W, Lin CH, Yang J, Shang C,
Nuernberg ST, Jin KK, Xu W, Lin CY, Lin CJ, et al: A long noncoding
RNA protects the heart from pathological hypertrophy. Nature.
514:102–106. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
De Lemos JA, Mcguire DK and Drazner MH:
B-type natriuretic peptide in cardiovascular disease. Lancet.
362:316–322. 2003.PubMed/NCBI View Article : Google Scholar
|
